Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.
The outbreaks of the past decade have taught us that new infectious diseases continue to emerge and spread as a result of global changes. These changes include population growth, an increase in livestock and agriculture to feed the population, exponential growth of travel (tourism and trade), and climate change. Infectious diseases do not confine themselves to national borders and can spread globally, as has been shown by Zika, Ebola, MERS, and bird flu viruses. What these outbreaks have in common is that they arise unexpectedly and put our healthcare systems to the test. When an outbreak occurs, it is often difficult to intervene because there is a lack of reliable diagnostics, treatment, and vaccines at short notice.
Masterclass with Jeremy Farrar, Marion Koopmans, Ron Fouchier
Date: Thursday 4 October
Time: 15.00 – 17.00
Location: Erasmus MC, Rotterdam
Registration via: [email protected]
Six leading researchers received the NWO Spinoza Prize and the Stevin Prize today from Ingrid van Engelshoven, Minister of Education, Culture and Science. The prizes are the highest distinctions in Dutch science. Cell biologist Anna Akhmanova, biophysicist Marileen Dogterom, social psychologist Carsten de Dreu, historian Beatrice de Graaf, virologist Marion Koopmans and microbiologist John van...
On 28 May, the RIVM published a report on the current state of knowledge about bacteriophages. The RIVM study was commissioned by the Ministry of Health, Welfare and Sport after publications in the media about phage therapy. Since the television broadcast Dokters van Morgen, microbiologist Marc Bonten of the UMC Utrecht is regularly confronted with...
The Netherlands Antibiotic Development Platform (NADP) launched a novel funding opportunity during the NADP Voucher Event on 22 May 2018. The NADP Vouchers will support researchers and small- or medium-sized enterprises to bring their novel antibiotics and alternatives a step closer to the clinic.
On 22 February, an international symposium was organized on the possibilities of phage therapy in the treatment of patients with infections due to resistant bacteria.